Dearborn Partners LLC Novo Nordisk A S Transaction History
Dearborn Partners LLC
- $2.35 Billion
- Q4 2024
A detailed history of Dearborn Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Dearborn Partners LLC holds 3,972 shares of NVO stock, worth $231,686. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,972
Previous 3,572
11.2%
Holding current value
$231,686
Previous $425,000
19.76%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding NVO
# of Institutions
1,867Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.16 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$904 Million0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$758 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$737 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$712 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $132B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...